Valuation (21%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 32.53 | 31.62 |
PEG Ratio (TTM) | -2.93 | 78.50 |
P/S Ratio (TTM) | 6.13 | 7.26 |
P/B Ratio (TTM) | 1.60 | 6.23 |
P/FCF Ratio (TTM) | -2.64 | 4.74 |
Price to 5YR AVG Earnings Ratio | 15,633.66 | 167.53 |
Price to 5YR AVG FCF Ratio | -1.61 | -32.92 |
Profitability (30%) |
Company | Industry |
---|---|---|
ROA (TTM) | 1.20% | 0.88% |
ROE (TTM) | 4.94% | 8.25% |
Net Profit Margin (TTM) | 18.74% | -16.04% |
ROIC 5YR AVG | 3.27% | 4.02% |
Growth (63%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 3.65% | -207.03% | -108.75% |
Revenue | 13.03% | 69.10% | 39.69% |
Net Income | 5.21% | -252.56% | -127.15% |
Cash Flow | 14.79% | 35.98% | 25.43% |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.59 | 1.18 |
Quick Ratio (TTM) | 0.59 | 0.96 |
D/E Ratio (TTM) | 2.39 | 1.29 |
Interest Coverage (TTM) | 1.96 | 6.32 |
Piotroski F-Score | 6 | 5 |
Altman Z-Score | 0.46 | 1.95 |
LTL to 5YR AVG FCF | -2.01 | -28.70 |
Shares Outstanding Growth 5YR AVG | 17.41% | 2.50% |